Cancer Family
Lung Neoplasm
CI-CAN-00000221Explore in graph →
Non-malignant2,724 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000221Explore in graph →
Clinical trials
11,600 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00989690 | Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer | unknown | Phase 3 | 275 | Istituto Scientifico H. San RaffaeleOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00004209 | Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | unknown | Phase 3 | — | Cancer Research UKOTHER | 1 | Aug 7, 2013 |
| clinicaltrials |
| NCT00955695 | Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer | unknown | Phase 3 | 242 | National Cancer Center, KoreaOTHER_GOV | 0 | Aug 2, 2013 | clinicaltrials |
| NCT01555710 | Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) | unknown | Phase 3 | 548 | Alaunos TherapeuticsINDUSTRY | 11 | May 21, 2013 | clinicaltrials |
| NCT01802021 | Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients(QSYQT) | unknown | Phase 2 / Phase 3 | 120 | Chang Gung Memorial HospitalOTHER | 1 | Mar 1, 2013 | clinicaltrials |
| NCT01731548 | A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 500 | Zhejiang Cancer HospitalOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01560195 | A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy | unknown | Phase 3 | 150 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Nov 6, 2012 | clinicaltrials |
| NCT01481259 | Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | People's Hospital of Guangxi Zhuang Autonomous RegionOTHER | 1 | Jul 3, 2012 | clinicaltrials |
| NCT01593293 | Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer(ACE) | unknown | Phase 3 | 266 | Asan Medical CenterOTHER | 1 | May 8, 2012 | clinicaltrials |
| NCT00706862 | Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer(FORTIS-C) | unknown | Phase 3 | 1,100 | AgennixINDUSTRY | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00637910 | Tarceva Italian Lung Optimization tRial(TAILOR) | unknown | Phase 3 | 850 | Fatebenefratelli and Ophthalmic HospitalOTHER | 1 | Feb 24, 2012 | clinicaltrials |
| NCT00246727 | Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer | unknown | Phase 3 | 300 | Sun Farm CorporationOTHER | 1 | Oct 31, 2011 | clinicaltrials |
| NCT00519805 | Dalteparin in Preventing Blood Clots in Patients With Lung Cancer | unknown | Phase 3 | 2,200 | Velindre NHS TrustOTHER_GOV | 1 | Aug 8, 2011 | clinicaltrials |
| NCT01301560 | Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis | unknown | Phase 3 | 176 | Samsung Medical CenterOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT01053624 | Concomitant Tracheostomy and Lung Resection | unknown | Phase 3 | 60 | University Hospital, Clermont-FerrandOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT00657423 | Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 80 | Xijing HospitalOTHER | 1 | Sep 17, 2010 | clinicaltrials |
| NCT01158170 | Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001) | unknown | Phase 3 | 200 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT01130766 | Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 176 | Samsung Medical CenterOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00576914 | Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer | unknown | Phase 3 | 1,108 | Chinese Academy of SciencesOTHER_GOV | 1 | Mar 9, 2010 | clinicaltrials |
| NCT01066195 | Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy | unknown | Phase 3 | 129 | Samsung Medical CenterOTHER | 1 | Feb 10, 2010 | clinicaltrials |
| NCT01048970 | Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer | unknown | Phase 2 / Phase 3 | 120 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 14, 2010 | clinicaltrials |
| NCT01041833 | Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker | unknown | Phase 3 | 230 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 1, 2010 | clinicaltrials |
| NCT01003522 | Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer(RESTORE-AIR) | unknown | Phase 3 | 60 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 28, 2009 | clinicaltrials |
| NCT00300729 | Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy(CYCLUS) | unknown | Phase 3 | 319 | University Hospital, LinkoepingOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00465491 | Study of Picoplatin Efficacy After Relapse(SPEAR) | unknown | Phase 3 | 399 | Poniard PharmaceuticalsINDUSTRY | 15 | Apr 14, 2009 | clinicaltrials |
| NCT00002858 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | unknown | Phase 3 | 280 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00077220 | Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer | unknown | Phase 3 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00273494 | Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2 | unknown | Phase 3 | 406 | Rigshospitalet, DenmarkOTHER | 1 | May 22, 2008 | clinicaltrials |
| NCT00268684 | Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC | unknown | Phase 3 | 381 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Feb 28, 2006 | clinicaltrials |
| NCT00168896 | A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage | unknown | Phase 2 / Phase 3 | 286 | Charite University, Berlin, GermanyOTHER | 1 | Feb 14, 2006 | clinicaltrials |
| NCT00139971 | Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer | unknown | Phase 3 | 600 | West Japan Thoracic Oncology GroupOTHER | 1 | Jan 6, 2006 | clinicaltrials |
| NCT00265694 | Random Trial for Elderly Patients With NSCLC | unknown | Phase 3 | — | Inje UniversityOTHER | 1 | Dec 15, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Aug 12, 2013source: clinicaltrials